Adjunct Faculty
Adjunct faculty typically have an academic or research appointment at another institution and contribute or collaborate with one or more School of Medicine faculty members or programs.
Adjunct rank detailsGilles Tamagnan, PhD
Associate Professor Adjunct, PsychiatryAbout
Copy Link
Titles
Associate Professor Adjunct, Psychiatry
Departments & Organizations
Education & Training
- PhD
- University Joseph Pourier (1993)
Research
Copy Link
Research at a Glance
Yale Co-Authors
Frequent collaborators of Gilles Tamagnan's published research.
Publications Timeline
A big-picture view of Gilles Tamagnan's research output by year.
John Seibyl, MD
Yiyun Huang, PhD
Marina Picciotto, PhD
Mike Ming-Qiang Wenn
Richard Carson, PhD
Daniel Holden
75Publications
1,422Citations
Publications
2026
Discovery of the First Brain-Penetrant Radioligands for Visualizing the GABA Transporter 1 (GAT-1): Synthesis, In Vitro Screening, and In Vivo Evaluation in Nonhuman Primates
Gu J, Wang C, Gobbi L, Honer M, Zheng M, Gravel P, Gao H, Zhang L, Ropchan J, Nabulsi N, Borroni E, Tamagnan G, Carson R, Huang Y. Discovery of the First Brain-Penetrant Radioligands for Visualizing the GABA Transporter 1 (GAT-1): Synthesis, In Vitro Screening, and In Vivo Evaluation in Nonhuman Primates. Journal Of Medicinal Chemistry 2026, 69: 8852-8868. PMID: 41945380, DOI: 10.1021/acs.jmedchem.5c03014.Peer-Reviewed Original ResearchTau conformation, distribution and PET imaging correlations in progressive supranuclear palsy
Dong C, Ma J, Qiao H, Tamagnan G, Chan P, Liu S. Tau conformation, distribution and PET imaging correlations in progressive supranuclear palsy. Translational Neurodegeneration 2026, 15: 14. PMID: 41882788, PMCID: PMC13015156, DOI: 10.1186/s40035-026-00545-5.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsCitationsAltmetricFirst human whole-body biodistribution and dosimetry analysis of [18F]LW223, a novel TSPO PET radiotracer
Khaing P, MacAskill M, Xiao J, Liu S, Gu Z, Sun X, Xu T, Koglin N, Stephens A, Newby D, Guan Y, McErlain H, Sutherland A, Tamagnan G, Xie F, Tavares A. First human whole-body biodistribution and dosimetry analysis of [18F]LW223, a novel TSPO PET radiotracer. European Journal Of Nuclear Medicine And Molecular Imaging 2026, 53: 3951-3959. PMID: 41518399, PMCID: PMC13121222, DOI: 10.1007/s00259-025-07722-0.Peer-Reviewed Original ResearchCitationsAltmetric
2025
Monoamine Loss and Functional Connectivity Alterations in Patients With Parkinson's Disease and Depression
Xu B, Liu X, Barret O, Tamagnan G, Qiao H, Lu J, Zhang C, Chan P, Liu S. Monoamine Loss and Functional Connectivity Alterations in Patients With Parkinson's Disease and Depression. CNS Neuroscience & Therapeutics 2025, 31: e70705. PMID: 41450012, PMCID: PMC12741543, DOI: 10.1002/cns.70705.Peer-Reviewed Original ResearchCitationsToward Imaging of the GABA Transporter Type 1 In Vivo: Quantitative Evaluation of 4 Novel PET Radiotracers in Nonhuman Primates
Gravel P, Gu J, Wang C, Volpi T, Gallezot J, Holden D, Fowles K, Zheng M, Zhang L, Borroni E, Honer M, Gobbi L, Tamagnan G, Huang Y, Carson R. Toward Imaging of the GABA Transporter Type 1 In Vivo: Quantitative Evaluation of 4 Novel PET Radiotracers in Nonhuman Primates. Journal Of Nuclear Medicine 2025, 66: 1652-1658. PMID: 40908122, PMCID: PMC12487869, DOI: 10.2967/jnumed.125.270332.Peer-Reviewed Original ResearchCitationsAltmetric
2024
Striatal and Extrastriatal Monoaminergic Disruption in Progressive Supranuclear Palsy
Ma J, Dong C, Qiao H, Barret O, Tamagnan G, Mao W, Xu E, Zhang C, Lu J, Chan P, Liu S. Striatal and Extrastriatal Monoaminergic Disruption in Progressive Supranuclear Palsy. Movement Disorders 2024, 39: 847-854. PMID: 38477228, DOI: 10.1002/mds.29769.Peer-Reviewed Original ResearchCitationsAltmetric
2023
18F-FP-DTBZ PET/CT detectable associations between monoaminergic depletion in the putamen with rigidity and the pallidus with tremor in Parkinson's disease
Huang A, Liu S, Barret O, Qiao H, Tamagnan G, Liu X, Fan C, Li Z, Lu J, Chan P, Xu E. 18F-FP-DTBZ PET/CT detectable associations between monoaminergic depletion in the putamen with rigidity and the pallidus with tremor in Parkinson's disease. Parkinsonism & Related Disorders 2023, 120: 105979. PMID: 38241952, DOI: 10.1016/j.parkreldis.2023.105979.Peer-Reviewed Original ResearchCitations
2018
IC‐P‐220: CLINICAL UPDATE: 18F‐PI‐2620, A NEXT GENERATION TAU PET AGENT EVALUATED IN SUBJECTS WITH ALZHEIMER'S DISEASE AND PROGRESSIVE SUPRANUCLEAR PALSY
Stephens A, Seibyl J, Mueller A, Barret O, Berndt M, Madonia J, Kroth H, Bullich S, Pfeifer A, Muhs A, Tamagnan G, Marek K, Dinkelborg L. IC‐P‐220: CLINICAL UPDATE: 18F‐PI‐2620, A NEXT GENERATION TAU PET AGENT EVALUATED IN SUBJECTS WITH ALZHEIMER'S DISEASE AND PROGRESSIVE SUPRANUCLEAR PALSY. Alzheimer's & Dementia 2018, 14: p179-p179. DOI: 10.1016/j.jalz.2018.06.2287.Peer-Reviewed Original ResearchCitationsP1‐400: TAU AND ALPHA‐SYNUCLEIN SELECTIVE BINDING COMPOUNDS DERIVED FROM APRINOIA THERAPEUTIC'S PM‐PBB3 BINDING‐SITE FOCUSED COMPOUND COLLECTION
Tempest P, Ono M, Higuchi M, Shimada H, Suhara T, Zhang M, Tai C, Carroll V, Tamagnan G, Marek K, Barret O, Alagille D, Jang M. P1‐400: TAU AND ALPHA‐SYNUCLEIN SELECTIVE BINDING COMPOUNDS DERIVED FROM APRINOIA THERAPEUTIC'S PM‐PBB3 BINDING‐SITE FOCUSED COMPOUND COLLECTION. Alzheimer's & Dementia 2018, 14: p455-p455. DOI: 10.1016/j.jalz.2018.06.408.Peer-Reviewed Original ResearchIC‐P‐082: TAU AND ALPHA‐SYNUCLEIN SELECTIVE BINDING COMPOUNDS DERIVED FROM APRINOIA THERAPEUTIC'S PM‐PBB3 BINDING‐SITE FOCUSED COMPOUND COLLECTION
Tempest P, Ono M, Higuchi M, Shimada H, Suhara T, Tai C, Tamagnan G, Carroll V, Alagille D, Barret O, Marek K, Jang M. IC‐P‐082: TAU AND ALPHA‐SYNUCLEIN SELECTIVE BINDING COMPOUNDS DERIVED FROM APRINOIA THERAPEUTIC'S PM‐PBB3 BINDING‐SITE FOCUSED COMPOUND COLLECTION. Alzheimer's & Dementia 2018, 14: p71-p71. DOI: 10.1016/j.jalz.2018.06.2146.Peer-Reviewed Original Research
Get In Touch
Copy Link